1. Home
  2. SLS vs KINS Comparison

SLS vs KINS Comparison

Compare SLS & KINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • KINS
  • Stock Information
  • Founded
  • SLS 2012
  • KINS 1886
  • Country
  • SLS United States
  • KINS United States
  • Employees
  • SLS N/A
  • KINS N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • KINS Property-Casualty Insurers
  • Sector
  • SLS Health Care
  • KINS Finance
  • Exchange
  • SLS Nasdaq
  • KINS Nasdaq
  • Market Cap
  • SLS 185.3M
  • KINS 189.6M
  • IPO Year
  • SLS N/A
  • KINS N/A
  • Fundamental
  • Price
  • SLS $1.69
  • KINS $13.54
  • Analyst Decision
  • SLS Strong Buy
  • KINS
  • Analyst Count
  • SLS 1
  • KINS 0
  • Target Price
  • SLS $7.00
  • KINS N/A
  • AVG Volume (30 Days)
  • SLS 2.0M
  • KINS 154.9K
  • Earning Date
  • SLS 11-12-2025
  • KINS 10-28-2025
  • Dividend Yield
  • SLS N/A
  • KINS 1.45%
  • EPS Growth
  • SLS N/A
  • KINS 325.10
  • EPS
  • SLS N/A
  • KINS 2.04
  • Revenue
  • SLS N/A
  • KINS $183,702,376.00
  • Revenue This Year
  • SLS N/A
  • KINS $41.35
  • Revenue Next Year
  • SLS N/A
  • KINS $12.33
  • P/E Ratio
  • SLS N/A
  • KINS $6.77
  • Revenue Growth
  • SLS N/A
  • KINS 28.36
  • 52 Week Low
  • SLS $0.77
  • KINS $8.36
  • 52 Week High
  • SLS $2.27
  • KINS $22.40
  • Technical
  • Relative Strength Index (RSI)
  • SLS 42.73
  • KINS 43.99
  • Support Level
  • SLS $1.65
  • KINS $13.38
  • Resistance Level
  • SLS $2.01
  • KINS $14.17
  • Average True Range (ATR)
  • SLS 0.11
  • KINS 0.49
  • MACD
  • SLS -0.02
  • KINS 0.07
  • Stochastic Oscillator
  • SLS 11.11
  • KINS 32.62

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About KINS Kingstone Companies Inc.

Kingstone Companies Inc is a multi-line regional property and casualty insurance holding company. It offers insurance policies to small and mid-sized businesses as well as to individuals.

Share on Social Networks: